Erratum: Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response (Journal of Virology (2014) 88:9 (4866-4876) DOI: 10.1128/JVI.03649-13);Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response

Journal of Virology

Volumn 88, Issue 9, 2014, Pages 4866-4876

  Siu, Kam Leung ^a   Yeung, Man Lung ^b   Kok, Kin Hang ^a   Yuen, Kit San ^a   Kew, Chun ^a   Lui, Pak Yin ^a   Chan, Chi Ping ^a   Tse, Herman ^b   Woo, Patrick C Y ^b   Yuen, Kwok Yung ^b   Jin, Dong Yan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; MAVS PROTEIN; MDA5 PROTEIN; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS 4A; PACT PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I; TBK1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; INNATE IMMUNITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; RNA SEQUENCE; SENDAI VIRUS;

CELL LINE; CORONAVIRUS; DEAD-BOX RNA HELICASES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; INTERFERONS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; RNA-BINDING PROTEINS; VIRAL PROTEINS;

EID: 84895534920     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/jvi.01504-22     Document Type: Erratum

References (53)

1. Memish ZA, Zumla AI, Al-Hakeem RF, Al-Rabeeah AA, Stephens GM. 2013. Family cluster of Middle East respiratory syndrome coronavirus infections. N. Engl. J. Med. 368:2487-2494. http://dx.doi.org/10.1056/NEJMoa1303729.
2. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA, KSA MERS-CoV Investigation Team. 2013. Hospital outbreak of Middle East respiratory syndrome coronavirus. N. Engl. J. Med. 369:407-416. http://dx.doi.org/10.1056/NEJMoa1306742.
3. Breban R, Riou J, Fontanet A. 2013. Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. Lancet 382:694-699. http://dx.doi.org/10.1016/S0140-6736(13) 61492-0.
4. van Boheemen S, de Graaf M, Lauber C, Bestebroer TM, Raj VS, Zaki AM, Osterhaus AD, Haagmans BL, Gorbalenya AE, Snijder EJ, Fouchier RA. 2012. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 3(6):e00473-12. http://dx.doi.org/10.1128/mBio.00473-12.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. 2012. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367:1814-1820. http://dx.doi.org/10.1056/NEJMoa1211721.
6. de Groot RJ, Baker SC, Baric RS, Brown CS, Drosten C, Enjuanes L, Fouchier RA, Galiano M, Gorbalenya AE, Memish ZA, Perlman S, Poon LLM, Snijder EJ, Stephens GM, Woo PCY, Zaki AM, Zambon M, Ziebuhr J. 2013. Middle East respiratory syndrome coronavirus (MERSCoV): announcement of the Coronavirus Study Group. J. Virol. 87:7790-7792. http://dx.doi.org/10.1128/JVI.01244-13.
7. Chan JFW, Lau SKP, Woo PCY. 2013. The emerging novel Middle East respiratory syndrome coronavirus: the "knowns" and "unknowns".J. Formos. Med. Assoc. 112:372-381. http://dx.doi.org/10.1016/j.jfma.2013.05.010.
8. Woo PCY, Wang M, Lau SKP, Xu H, Poon RW, Guo R, Wong BH, Gao K, Tsoi HW, Huang Y, Li KS, Lam CS, Chan KH, Zheng BJ, Yuen KY. 2007. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J. Virol. 81:1574-1585. http://dx.doi.org/10.1128/JVI.02182-06.
9. Lau SKP, Li KSM, Tsang AKL, Lam CS, Ahmed S, Chen H, Chan KH, Woo PCY, Yuen KY. 2013. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of Pipistrellus bat coronavirusHKU5in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J. Virol. 87:8638-8650. http://dx.doi.org/10.1128/JVI.01055-13.
10. Memish ZA, Mishra N, Olival KJ, Fagbo SF, Kapoor V, Epstein JH, AlHakeem R, Durosinloun A, Al Asmari M, Islam A, Kapoor A, Briese T, Daszak P, Al Rabeeah AA, Lipkin WI. 2013. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg. Infect. Dis. 19:1819-1823. http://dx.doi.org/10.3201/eid1911.131172.
11. Lelli D, Papetti A, Sabelli C, Rosti E, Moreno A, Boniotti MB. 2013. Detection of coronaviruses in bats of various species in Italy. Viruses 5:2679-2689. http://dx.doi.org/10.3390/v5112679.
12. Ithete NL, Stoffberg S, Corman VM, Cottontail VM, Richards LR, Schoeman MC, Drosten C, Drexler JF, Preiser W. 2013. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis. 19:1697-1699. http://dx.doi.org/10.3201/eid1910.130946.
13. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, Muth D, Raj VS, Vries LS, Corman VM, Drexler JF, Smits SL, El Tahir YE, De Sousa R, van Beek J, Nowotny N, van Maanen K, Hidalgo-Hermoso E, Bosch BJ, Rottier P, Osterhaus A, Gortázar-Schmidt C, Drosten C, Koopmans MP. 2013. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect. Dis. 13:859-866. http://dx.doi.org/10.1016/S1473-3099(13)70164-6.
14. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, Siu LY, Shehata MM, Kayed AS, Moatasim Y, Li M, Poon LL, Guan Y, Webby RJ, Ali MA, Peiris JS, Kayali G. 2013. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 18(36):pii=20574. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20574.
15. Guery B, Poissy J, el Mansouf L, Séjourné C, Ettahar N, Lemaire X, Vuotto F, Goffard A, Behillil S, Enouf V, Caro V, Mailles A, Che D, Manuguerra JC, Mathieu D, Fontanet A, van der Werf S. 2013. Clinical features and viral diagnosis of two cases of infection with Middle East respiratory syndrome coronavirus: a report of nosocomial transmission. Lancet 381:2265-2272. http://dx.doi.org/10.1016/S0140-6736(13)60982-4.
16. Cheng VCC, Lau SKP, Woo PCY, Yuen KY. 2007. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin. Microbiol. Rev. 20:660-694. http://dx.doi.org/10.1128/CMR.00023-07.
17. Totura AL, Baric RS. 2012. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon. Curr. Opin. Virol. 2:264-275. http://dx.doi.org/10.1016/j.coviro.2012.04.004.
18. Kindler E, Jónsdóttir HR, Muth D, Hamming OJ, Hartmann R, Rodriguez R, Geffers R, Fouchier RA, Drosten C, Müller MA. 2013. Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. mBio 4(1):e00611-12. http://dx.doi.org/10.1128/mBio.00611-12.
19. Chan JFW, Chan KH, Choi GK, To KKW, Tse H, Cai JP, Yeung ML, Cheng VCC, Chen H, Che XY, Lau SKP, Woo PCY, Yuen KY. 2013. Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J. Infect. Dis. 207:1743-1752. http://dx.doi.org/10.1093/infdis/jit123.
20. Falzarano D, de Wit E, Rasmussen AL, Feldmann F, Okumura A, Scott DP, Brining D, Bushmaker T, Martellaro C, Baseler L, Benecke AG, Katze MG, Munster VJ, Feldmann H. 2013. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Nat. Med. 19:1313-1317. http://dx.doi.org/10.1038/nm.3362.
21. Chan RW, Chan MC, Agnihothram S, Chan LL, Kuok DI, Fong JH, Guan Y, Poon LLM, Baric RS, Nicholls JM, Peiris JSM. 2013. Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures. J. Virol. 87: 6604-6614. http://dx.doi.org/10.1128/JVI.00009-13.
22. de Wilde AH, Raj VS, Oudshoorn D, Bestebroer TM, van Nieuwkoop S, Limpens RW, Posthuma CC, van der Meer Y, Bárcena M, Haagmans BL, Snijder EJ, van den Hoogen BG. 2013. MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment. J. Gen. Virol. 94:1749-1760. http://dx.doi.org/10.1099/vir.0.052910-0.
23. Zhou J, Chu H, Li C, Wong BHY, Cheng ZS, Poon VKM, Sun T, Lau CCY, Wong KKY, Chan JYW, Chan JFW, To KKW, Chan KH, Zheng BJ, Yuen KY. 21 October 2013. Active MERS-CoV replication and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J. Infect. Dis. [Epub ahead of print.] http://dx.doi.org/10.1093/infdis/jit504.
24. Zielecki F, Weber M, Eickmann M, Spiegelberg L, Zaki AM, Matrosovich M, Becker S, Weber F. 2013. Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J. Virol. 87:5300-5304. http://dx.doi.org/10.1128/JVI.03496-12.
25. Lau SKP, Lau CCY, Chan KH, Li CPY, Chen H, Jin DY, Chan JFW, Woo PCY, Yuen KY. 2013. Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. J. Gen. Virol. 94:2679-2690. http://dx.doi.org/10.1099/vir.0.055533-0.
26. Moresco EM, LaVine D, Beutler B. 2011. Toll-like receptors. Curr. Biol. 21:R488-R493. http://dx.doi.org/10.1016/j.cub.2011.05.039.
27. Goubau D, Deddouche S, Reis e Sousa C. 2013. Cytosolic sensing of viruses. Immunity 38:855-869. http://dx.doi.org/10.1016/j.immuni.2013.05.007.
28. Li J, Liu Y, Zhang X. 2010. Murine coronavirus induces type I interferon in oligodendrocytes through recognition by RIG-I and MDA5. J. Virol. 84:6472-6482. http://dx.doi.org/10.1128/JVI.00016-10.
29. Kok KH, Lui PY, Ng MHJ, Siu KL, Au SWN, Jin DY. 2011. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 9:299-309. http://dx.doi.org/10.1016/j.chom.2011.03.007.
30. Luthra P, Ramanan P, Mire CE, Weisend C, Tsuda Y, Yen B, Liu G, Leung DW, Geisbert TW, Ebihara H, Amarasinghe GK, Basler CF. 2013. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14:74-84. http://dx.doi.org/10.1016/j.chom.2013.06.010.
31. Kew C, Lui PY, Chan CP, Liu X, Au SWN, Mohr I, Jin DY, Kok KH. 2013. Suppression of PACT-induced type I interferon production by herpes simplex virus type 1 Us11 protein. J. Virol. 87:13141-13149. http://dx.doi.org/10.1128/JVI.02564-13.
32. Kok KH, Jin DY. 2013. Balance of power in host-virus arms races. Cell Host Microbe 14:5-6. http://dx.doi.org/10.1016/j.chom.2013.07.004.
33. Niemeyer D, Zillinger T, Muth D, Zielecki F, Horvath G, Suliman T, Barchet W, Weber F, Drosten C, Müller MA. 2013. Middle East respiratory syndrome coronavirus accessory protein 4a is a type I interferon antagonist. J. Virol. 87:12489-12495. http://dx.doi.org/10.1128/JVI.01845-13.
34. Yang Y, Zhang L, Geng H, Deng Y, Huang B, Guo Y, Zhao Z, Tan W. 2013. The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists. Protein Cell 4:951-961. http://dx.doi.org/10.1007/s13238-013-3096-8.
35. Siu KL, Kok KH, Ng MHJ, Poon VKM, Yuen KY, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirus M protein inhibits type I interferon production by impeding the formation of TRAF3 ·TANK · TBK1/IKKe complex. J. Biol. Chem. 284:16202-16209. http://dx.doi.org/10.1074/jbc.M109.008227.
36. Kok KH, Jin DY. 2006. Influenza A virus NS1 protein does not suppress RNA interference in mammalian cells. J. Gen. Virol. 87:2639-2644. http://dx.doi.org/10.1099/vir.0.81764-0.
37. Yoneyama M, Suhara W, Fukuhara Y, Sato M, Ozato K, Fujita T. 1996. Autocrine amplification of type I interferon gene expression mediated by interferon stimulated gene factor 3 (ISGF3). J. Biochem. 120:160-169. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a021379.
38. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, Taira K, Akira S, Fujita T. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730-737. http://dx.doi.org/10.1038/ni1087.
39. Groseth A, Charton JE, Sauerborn M, Feldmann F, Jones SM, Hoenen T, Feldmann H. 2009. The Ebola virus ribonucleoprotein complex: a novel VP30-L interaction identified. Virus Res. 140:8-14. http://dx.doi.org/10.1016/j.virusres.2008.10.017.
40. Woo PCY, Lau SKP, Li KSM, Poon RWS, Wong BHL, Tsoi HW, Yip BCK, Huang Y, Chan KH, Yuen KY. 2006. Molecular diversity of coronaviruses in bats. Virology 351:180-187. http://dx.doi.org/10.1016/j.virol.2006.02.041.
41. Siu KL, Chan CP, Woo PCY, Jin DY. 2014. Comparative analysis of the activation of unfolded protein response by spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus HKU1. Cell Biosci. 4:3. http://dx.doi.org/10.1186/2045-3701-4-3.
42. Siu KL, Chan CP, Kok KH, Woo PCY, Jin DY. 10 February 2014. Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain. Cell. Mol. Immunol. [Epub ahead of print.] http://dx.doi.org/10.1038/cmi.2013.61.
43. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59. http://dx.doi.org/10.1016/0378-1119(89)90358-2.
44. Kok KH, Ng MHJ, Ching YP, Jin DY. 2007. Human TRBP and PACT interact with each other and associate with Dicer to facilitate the production of small interfering RNA. J. Biol. Chem. 282:17649-17657. http://dx.doi.org/10.1074/jbc.M611768200.
45. Tang HMV, Gao WW, Chan CP, Siu YT, Wong CM, Kok KH, Ching YP, Takemori H, Jin DY. 2013. LKB1 tumor suppressor and saltinducible kinases negatively regulate human T-cell leukemia virus type 1 transcription. Retrovirology 10:40. http://dx.doi.org/10.1186/1742-4690-10-40.
46. Ng MHJ, Ho TH, Kok KH, Siu KL, Li J, Jin DY. 2011. MIP-T3 is a negative regulator of innate type I interferon response. J. Immunol. 187: 6473-6482. http://dx.doi.org/10.4049/jimmunol.1100719.
47. Chan CP, Siu YT, Kok KH, Ching YP, Tang HMV, Jin DY. 2013. Group I p21-activated kinases facilitate Tax-mediated transcriptional activation of the human T-cell leukemia virus type 1 long terminal repeats. Retrovirology 10:47. http://dx.doi.org/10.1186/1742-4690-10-47.
48. Siu KL, Chan CP, Chan C, Zheng BJ, Jin DY. 2009. Severe acute respiratory syndrome coronavirus nucleocapsid protein does not modulate transcription of human FGL2 gene. J. Gen. Virol. 90:2107-2113. http://dx.doi.org/10.1099/vir.0.009209-0.
49. Yount B, Roberts RS, Sims AC, Deming D, Frieman MB, Sparks J, Denison MR, Davis N, Baric RS. 2005. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice. J. Virol. 79:14909-14922. http://dx.doi.org/10.1128/JVI.79.23.14909-14922.2005.
50. Almazán F, Dediego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L. 2013. Engineering a replicationcompetent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. mBio 4(5):e00650-13. http://dx.doi.org/10.1128/mBio.00650-13.
51. Baker ML, Schountz T, Wang LF. 2013. Antiviral immune responses of bats: a review. Zoonoses Public Health 60:104-116. http://dx.doi.org/10.1111/j.1863-2378.2012.01528.x.
52. Chan JFW, To KKW, Tse H, Jin DY, Yuen KY. 2013. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends Microbiol. 21:544-555. http://dx.doi.org/10.1016/j.tim.2013.05.005.
53. Scobey T, Yount BL, Sims AC, Donaldson EF, Agnihothram SS, Menachery VD, Graham RL, Swanstrom J, Bove PF, Kim JD, Grego S, Randell SH, Baric RS. 2013. Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus. Proc. Natl. Acad. Sci. U. S. A. 110:16157-16162. http://dx.doi.org/10.1073/pnas.1311542110.